Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yuki Terai"'
Autor:
Xuan Du, Erica Yada, Yuki Terai, Takuya Takahashi, Hideyuki Nakanishi, Hiroki Tanaka, Hidetaka Akita, Keiji Itaka
Publikováno v:
Pharmaceutics, Vol 15, Iss 9, p 2291 (2023)
The growing significance of messenger RNA (mRNA) therapeutics in diverse medical applications, such as cancer, infectious diseases, and genetic disorders, highlighted the need for efficient and safe delivery systems. Lipid nanoparticles (LNPs) have s
Externí odkaz:
https://doaj.org/article/bbea13e3452e44a6b84880f314df846f
Autor:
Giuseppe Pezzotti, Wenliang Zhu, Yuki Terai, Elia Marin, Francesco Boschetto, Komei Kawamoto, Keiji Itaka
Publikováno v:
Materials Today Bio, Vol 13, Iss , Pp 100210- (2022)
While joint arthroplasty remains nowadays the most popular option available to repair chronically degenerated osteoarthritic joints, possibilities are recently emerging for regeneration of damaged cartilage rather than its replacement with artificial
Externí odkaz:
https://doaj.org/article/42ecb19639834faa92c75f99216a110f
Autor:
Jia Deng, Yuta Fukushima, Kosuke Nozaki, Hideyuki Nakanishi, Erica Yada, Yuki Terai, Kenji Fueki, Keiji Itaka
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1785 (2022)
Messenger RNA (mRNA) is an emerging drug modality for protein replacement therapy. As mRNA efficiently provides protein expression in post-mitotic cells without the risk of insertional mutagenesis, direct delivery of mRNA can be applied, not only as
Externí odkaz:
https://doaj.org/article/916d013a03e4460db62174803c5654ef